BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21553499)

  • 1. [Distribution and force spectroscopy of CD20 antigen-antibody binding on the B cell surface].
    Wang Q; Lu Y; Li S; Wang M; Cai J
    Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):131-6. PubMed ID: 21553499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes.
    Yağci M; Akar I; Sucak GT; Haznedar R
    Leuk Res; 2005 Jul; 29(7):735-8. PubMed ID: 15927668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting CD20-rituximab specific interactions on lymphoma cells using atomic force microscopy.
    Li M; Liu L; Xi N; Wang Y; Dong Z; Li G; Xiao X; Zhang W
    Sci China Life Sci; 2010 Oct; 53(10):1189-95. PubMed ID: 20953941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
    Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition.
    Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W
    J Mol Recognit; 2013 Sep; 26(9):432-8. PubMed ID: 23836471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
    Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
    Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
    Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
    Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
    Wang L; Abbasi F; Gaigalas AK; Vogt RF; Marti GE
    Cytometry B Clin Cytom; 2006 Nov; 70(6):410-5. PubMed ID: 16967494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
    Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
    Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia.
    Laprevotte E; Ysebaert L; Klein C; Valleron W; Blanc A; Gross E; Laurent G; Fournié JJ; Quillet-Mary A
    Leuk Res; 2013 Apr; 37(4):440-6. PubMed ID: 23259986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16.
    de Romeuf C; Dutertre CA; Le Garff-Tavernier M; Fournier N; Gaucher C; Glacet A; Jorieux S; Bihoreau N; Behrens CK; Béliard R; Vieillard V; Cazin B; Bourel D; Prost JF; Teillaud JL; Merle-Béral H
    Br J Haematol; 2008 Mar; 140(6):635-43. PubMed ID: 18302712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL.
    Klepfish A; Gilles L; Ioannis K; Rachmilewitz EA; Schattner A
    Ann N Y Acad Sci; 2009 Sep; 1173():865-73. PubMed ID: 19758239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale distribution of CD20 on B-cell lymphoma tumour cells and its potential role in the clinical efficacy of rituximab.
    Li M; Xiao X; Zhang W; Liu L; Xi N; Wang Y
    J Microsc; 2014 Apr; 254(1):19-30. PubMed ID: 24499016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of the B-cell marker CD20.
    Ernst JA; Li H; Kim HS; Nakamura GR; Yansura DG; Vandlen RL
    Biochemistry; 2005 Nov; 44(46):15150-8. PubMed ID: 16285718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructure and force spectroscopy analysis of human peripheral blood CD4+ T cells using atomic force microscopy.
    Hu M; Wang J; Cai J; Wu Y; Wang X
    Biochem Biophys Res Commun; 2008 Sep; 374(1):90-4. PubMed ID: 18602891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.
    Bauvois B; De Meester I; Dumont J; Rouillard D; Zhao HX; Bosmans E
    Br J Cancer; 1999 Mar; 79(7-8):1042-8. PubMed ID: 10098734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale mapping and organization analysis of target proteins on cancer cells from B-cell lymphoma patients.
    Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W
    Exp Cell Res; 2013 Nov; 319(18):2812-21. PubMed ID: 23896027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.